1. Home
  2. UGRO vs INDP Comparison

UGRO vs INDP Comparison

Compare UGRO & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$6.31

Market Cap

1.9M

ML Signal

HOLD

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

N/A

Current Price

$1.73

Market Cap

4.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UGRO
INDP
Founded
2014
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9M
4.5M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
UGRO
INDP
Price
$6.31
$1.73
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
56.3K
20.1K
Earning Date
02-17-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,008,850.00
N/A
Revenue This Year
$98.41
N/A
Revenue Next Year
$23.34
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.27
52 Week High
$4.50
$13.24

Technical Indicators

Market Signals
Indicator
UGRO
INDP
Relative Strength Index (RSI) 80.95 41.40
Support Level $0.28 $1.65
Resistance Level N/A $2.18
Average True Range (ATR) 0.60 0.14
MACD 0.16 -0.00
Stochastic Oscillator 86.02 22.78

Price Performance

Historical Comparison
UGRO
INDP

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: